Neurologic Complications After Liver Transplant: Experience at a Single Center

dc.contributor.authorDerle, Eda
dc.contributor.authorKibaroglu, Seda
dc.contributor.authorOcal, Ruhsen
dc.contributor.authorKirnap, Mahir
dc.contributor.authorCan, Ufuk
dc.contributor.authorBenli, Sibel
dc.contributor.authorHaberal, Mehmet
dc.contributor.orcID0000-0003-2122-1016en_US
dc.contributor.orcID0000-0002-3964-268Xen_US
dc.contributor.orcID0000-0001-8689-417Xen_US
dc.contributor.orcID0000-0002-3462-7632en_US
dc.contributor.orcID0000-0002-9975-3170en_US
dc.contributor.pubmedID25894184en_US
dc.contributor.researcherIDV-3553-2017en_US
dc.contributor.researcherIDAAH-9198-2019en_US
dc.contributor.researcherIDAAI-8830-2021en_US
dc.contributor.researcherIDAAJ-2956-2021en_US
dc.contributor.researcherIDAAJ-2999-2021en_US
dc.contributor.researcherIDAAJ-8097-2021en_US
dc.contributor.researcherIDAAJ-4403-2021en_US
dc.date.accessioned2024-02-13T10:17:46Z
dc.date.available2024-02-13T10:17:46Z
dc.date.issued2015
dc.description.abstractObjectives: Neurologic complications occur frequently after liver transplants. Up to 43% of patients experience severe postsurgical neurologic complications. These complications are significantly associated with longer hospital stay, morbidity, and mortality. The aim of this retrospective study was to evaluate the type and incidence of neurologic complications after liver transplants in adult patients. Materials and Methods: We retrospectively evaluated the medical records of 176 adult patients who had undergone liver transplants between 1995 and 2013. We recorded the demographic data, type of neurologic complications, type, and level of immunosuppressive treatment, and cause of liver failure. Results: Our study sample consisted of 48 deceased-donor liver transplants and 128 living-donor transplants (n = 176). Fifty-three of the patients (30.1%) were female. The age range of the total sample was 18 to 66 years (mean age, 43.1 +/- 13.7 y). As immunosuppressive treatment, most patients received tacrolimus alone (52%) or tacrolimus combined with mycophenolate mofetil (33%). Neurologic complications occurred in 74 of the patients (42%). The most common neurologic complications were diffuse encephalopathy (22.2%) and seizure (14.2%). Other neurologic complications were posterior reversible encephalopathy (1.7%), peripheral neuropathy (1.7%), cerebrovascular disease (1.1%), and central nervous system infection (1.1%). Age, cause of liver failure, and type of transplant were not associated with occurrence of neurologic complications. Conclusions: There was a high incidence of neurologic complications after liver transplants. Diffuse encephalopathy and seizure were common complications. Physicians should be aware of the high risk of neurologic complications after liver transplants. Factors such as immunosuppressive toxicity and metabolic imbalance that predispose patients to neurologic complications after liver transplants should be evaluated immediately, and treatment of postoperative neurologic complications should be initiated as early as possible.en_US
dc.identifier.endpage330en_US
dc.identifier.issn1304-0855en_US
dc.identifier.issueSupplement 1en_US
dc.identifier.scopus2-s2.0-84939802300en_US
dc.identifier.startpage327en_US
dc.identifier.urihttp://hdl.handle.net/11727/11490
dc.identifier.volume13en_US
dc.identifier.wos000355058400068en_US
dc.language.isoengen_US
dc.relation.isversionof10.6002/ect.mesot2014.P177en_US
dc.relation.journalEXPERIMENTAL AND CLINICAL TRANSPLANTATIONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLiver transplanten_US
dc.subjectNeurologic complicationen_US
dc.subjectEncephalopathySeizureen_US
dc.titleNeurologic Complications After Liver Transplant: Experience at a Single Centeren_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: